Impax Asset Management Group PLC Repligen Corp Transaction History
Impax Asset Management Group PLC
- $19.8 Billion
- Q4 2024
A detailed history of Impax Asset Management Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Impax Asset Management Group PLC holds 1,051,939 shares of RGEN stock, worth $134 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
1,051,939
Previous 1,058,169
0.59%
Holding current value
$134 Million
Previous $157 Million
3.85%
% of portfolio
0.77%
Previous 0.69%
Shares
21 transactions
Others Institutions Holding RGEN
# of Institutions
483Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$963 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$908 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$649 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$215 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$196 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.06B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....